Species differences in peroxisome proliferation; mechanisms and relevance
- PMID: 10725473
- DOI: 10.1016/s0027-5107(99)00237-7
Species differences in peroxisome proliferation; mechanisms and relevance
Abstract
Peroxisome proliferators are a class of structurally diverse chemicals, which induce liver carcinogenesis in rodents through interaction and activation of the Peroxisome Proliferator-Activated Receptor alpha (PPARalpha). PPARalpha agonists elicit a powerful pleiotropic response, which include hypolipidaemia. We have examined the response of species that are classically unresponsive to peroxisome proliferators. Whereas hamster responds to PPARalpha agonists by hepatomegaly and induction of marker genes, the guinea pig does not undergo hepatomegaly or induction of marker genes, such as CYP4A13. Both the hamster and the guinea pig have PPARalpha, and the guinea pig receptor has been characterised to be fully functional, as demonstrated in reporter gene expression assays. However, the guinea pig PPARalpha is expressed at low levels in liver, and the currently favoured hypothesis to explain species differences in hepatic peroxisome proliferation invokes the low level of PPARalpha as the principal determinant of species responsiveness. However, the demonstration that guinea pigs and humans undergo hypolipidaemia induced by PPARalpha-agonists calls into question the mode of action of PPARalpha agonists in "non-responsive" species.
Similar articles
-
Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.Biochem J. 1998 Jun 15;332 ( Pt 3)(Pt 3):689-93. doi: 10.1042/bj3320689. Biochem J. 1998. PMID: 9620871 Free PMC article.
-
Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig.Mutat Res. 2000 Mar 17;448(2):213-25. doi: 10.1016/s0027-5107(99)00238-9. Mutat Res. 2000. PMID: 10725474
-
Molecular analysis of peroxisome proliferation in the hamster.Toxicol Appl Pharmacol. 2004 May 15;197(1):9-18. doi: 10.1016/j.taap.2004.01.019. Toxicol Appl Pharmacol. 2004. PMID: 15126070
-
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences.J Mol Endocrinol. 1999 Feb;22(1):1-8. doi: 10.1677/jme.0.0220001. J Mol Endocrinol. 1999. PMID: 9924174 Review.
-
Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha.Toxicol Lett. 2000 Mar 15;112-113:49-57. doi: 10.1016/s0378-4274(99)00243-x. Toxicol Lett. 2000. PMID: 10720712 Review.
Cited by
-
Current challenges and controversies in drug-induced liver injury.Drug Saf. 2012 Dec 1;35(12):1099-117. doi: 10.1007/BF03261997. Drug Saf. 2012. PMID: 23137150
-
PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. Introduction.Clin Cardiol. 2004 Jul;27(7 Suppl 4):IV1-2. doi: 10.1002/clc.4960271602. Clin Cardiol. 2004. PMID: 15470904 Free PMC article. No abstract available.
-
Safety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig.Toxicol Rep. 2024 Mar 19;12:345-355. doi: 10.1016/j.toxrep.2024.03.009. eCollection 2024 Jun. Toxicol Rep. 2024. PMID: 38560508 Free PMC article.
-
PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1314-23. doi: 10.1152/ajpheart.00618.2004. Epub 2004 Nov 4. Am J Physiol Heart Circ Physiol. 2005. PMID: 15528232 Free PMC article.
-
Organotypic modeling of human keratinocyte response to peroxisome proliferators.Cells Tissues Organs. 2012;196(5):431-41. doi: 10.1159/000336268. Epub 2012 Jun 5. Cells Tissues Organs. 2012. PMID: 22677707 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources